Gene · 9134
Papers2,792
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,792
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Netrin-1 inducing antiapoptotic effect of acute myeloid leukemia cells in a concentration-dependent manner through the Unc-5 netrin receptor B-focal adhesion kinase axis. | Cancer Biol Ther | 2023 | 37038247 | PubTator, text mining | PubMed |
| Identification of a centrosome-related prognostic signature for breast cancer. | Front Oncol | 2023 | 37035151 | PubTator, text mining | PubMed |
| Retraction: Knockdown of long non-coding RNA KCNQ1OT1 restrained glioma cells' malignancy by activating miR-370/CCNE2 axis. | Front Cell Neurosci | 2023 | 37032834 | PubTator, text mining | PubMed |
| Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer. | Front Oncol | 2023 | 37025585 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Inhibition of CDCP1 by 8-isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment. | Mol Oncol | 2023 | 37013960 | PubTator, text mining | PubMed |
| Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma. | J Exp Clin Cancer Res | 2023 | 37013646 | PubTator, text mining | PubMed |
| SMC4, a novel tumor prognostic marker and potential tumor therapeutic target. | Front Oncol | 2023 | 37007153 | PubTator, text mining | PubMed |
| A Novel Fibromodulin Antagonist Peptide RP4 Exerts Antitumor Effects on Colorectal Cancer. | Pharmaceutics | 2023 | 36986805 | PubTator, text mining | PubMed |
| Dendrimer-Mediated Delivery of Anticancer Drugs for Colon Cancer Treatment. | Pharmaceutics | 2023 | 36986662 | PubTator, text mining | PubMed |
| The Blood Microbiome and Health: Current Evidence, Controversies, and Challenges. | Int J Mol Sci | 2023 | 36982702 | PubTator, text mining | PubMed |
| MYCN Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors' Efficacy in Neuroblastoma Cells. | Int J Mol Sci | 2023 | 36982482 | PubTator, text mining | PubMed |
| Autophagy-Related MicroRNA: Tumor miR-125b and Thyroid Cancers. | Genes (Basel) | 2023 | 36980957 | PubTator, text mining | PubMed |
| Extracellular vesicle-associated microRNA signatures related to lymphovascular invasion in early-stage lung adenocarcinoma. | Sci Rep | 2023 | 36964242 | PubTator, text mining | PubMed |
| CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma. | BMC Cancer | 2023 | 36959566 | PubTator, text mining | PubMed |
| Conserved Molecular Players Involved in Human Nose Morphogenesis Underlie Evolution of the Exaggerated Snout Phenotype in Cichlids. | Genome Biol Evol | 2023 | 36930462 | PubTator, text mining | PubMed |
| SNHG18 inhibits bladder cancer cell proliferation by increasing p21 transcription through destabilizing c-Myc protein. | Cancer Cell Int | 2023 | 36927398 | PubTator, text mining | PubMed |
| Role of p53 in breast cancer progression: An insight into p53 targeted therapy. | Theranostics | 2023 | 36923534 | PubTator, text mining | PubMed |
| Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data. | Front Immunol | 2023 | 36911742 | PubTator, text mining | PubMed |
| Metabolic pathways of potential miRNA biomarkers derived from liquid biopsy in epithelial ovarian cancer. | Oncol Lett | 2023 | 36909377 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9134/papers?page=14